They were divided into 4 groups using eGFRcr and eGFRcys. Group A (n = 2,656); eGFRcr and eGFRcys equal or more than 60 (ml/min/1.73 m2), group B (n = 95); eGFRcr equal or more than 60 and eGFRcys less than 60, group C (n = 228); eGFRcr less than 60 and eGFRcys equal or more than 60, group D (n = 261); eGFRcr and eGFRcys less than 60. Results: The mean values of eGFRcr and eGFRcys were 80 ± 13 and 93 ± 18 in group A, 69 ± 10 and 53 ± 8 in group B, 55 ± 4 and 71 ± 16 in group C, 45 ± 12 and 45 ± 12 in group D, respectively. Among 4 groups, age, sex, lifestyle-related diseases, cardiovascular diseases,

systolic blood pressure, total cholesterol, uric acid and hemoglobin levels, proteinuria and hematuria were significantly different. The participants learn more of group B were Decitabine datasheet older, high frequent of hypertensive and proteinuria, had lower total cholesterol and hemoglobin levels, compared with those of group C. Conclusion: In this population, the evaluation of CKD using eGFRcr or eGFRcys is in agreement in 90 % of the participants. In the participants with eGFRcr equal or

more than 60 and eGFRcys less than 60, the risks such as older age, hypertension and proteinuria were evident and kidney function may progressively deteriorate in the future. JALALONMUHALI MAISARAH, NG KOK PENG, KONG WAI YEW, TAN LI PING, LIM SOO KUN Division of Nephrology, Department of Medicine, Faculty of Medicine, University of Malaya Introduction: Accurate measurement of renal function is very important, however gold standard measurement

of GFR can only be used on a very limited scale. Creatinine based GFR equations are widely used but the performance may vary. Cystatin-C is a recognized alternative marker in estimating GFR. Methods: This was a cross-sectional study, recruiting Cytidine deaminase patients from University Malaya Medical Centre Renal clinic. All patients underwent 51-Chromium EDTA clearance for measurement of GFR. Blood was obtained for serum creatinine and plasma cystatin-C. Estimated GFR calculation using creatinine and cystatin-C were then calculated with CKD-EPI formula. Data were analysed using SPSS version 20 and bias, precision and accuracy were determined. Results: A total of 60 subjects with mean age of 57.0 years and BMI of 26.3 kg/m2 were recruited. The mean reference GFR was 52.01 (28.43–61.85) ml/min/1.73 m2. Estimated GFR based on creatinine, cystatin-C and combination of creatinine-cystatin-C were 48.33 (27.51–56.00), 53.90 (30.77–70.30) and 51.03 (29.30–64.67) respectively. While all eGFR formulas correlated well with the reference GFR (0.932, 0.915, 0.925), overall the creatinine based equation performed the best with highest accuracy within 10,30 and 50%. Conclusions: The CKD-EPI using creatinine was better in estimating GFR in our small cohort of Malaysian population as compared to cystatin alone and creatinine-cystatin-C combination.